{"@context":"https://schema.org","@type":"NewsArticle","generatedAt":"2026-07-23T06:40:50.084Z","headline":"Neko Health 完成 7 亿美元C轮融资，将在纽约开设首家美国诊所","description":"Neko Health 完成 7 亿美元 C 轮融资，由 Lightspeed Venture Partners 领投，计划在纽约开设首家美国诊所。其 60 分钟非侵入性健康评估结合医学影像、血液检测与自有传感器，可筛查皮肤癌、心血管疾病等迹象。公司自 2023 年推出以来已完成 10 万次扫描，在英国和瑞典运营 8 家诊所。","url":"https://www.aioga.com/news/cmrnakp7k00pybic6jidcx726/","mainEntityOfPage":"https://www.aioga.com/news/cmrnakp7k00pybic6jidcx726/","datePublished":"2026-07-16T09:00:00.000Z","dateModified":"2026-07-16T09:00:00.000Z","inLanguage":"zh-CN","publisher":{"@type":"NewsMediaOrganization","name":"Aioga","url":"https://www.aioga.com"},"citation":["https://www.artificialintelligence-news.com/news/neko-health-700m-ai-body-scans-us","https://aihot.virxact.com/items/cmrnakp7k00pybic6jidcx726"],"canonicalUrl":"https://www.aioga.com/news/cmrnakp7k00pybic6jidcx726/","directAnswer":{"@type":"Answer","text":"Aioga 编辑摘要：Neko Health 完成 7 亿美元 C 轮融资，由 Lightspeed Venture Partners 领投，计划在纽约开设首家美国诊所。 Aioga 将其归入「行业动态」方向，重点关注它对真实使用和行业竞争的影响。","url":"https://www.aioga.com/news/cmrnakp7k00pybic6jidcx726/","dateCreated":"2026-07-16T09:00:00.000Z","author":{"@type":"Organization","@id":"https://www.aioga.com/authors/aioga-editorial/#editorial-team","name":"Aioga Editorial Team","url":"https://www.aioga.com/authors/aioga-editorial/"}},"evidence":[{"@type":"CreativeWork","name":"artificialintelligence-news.com source article","url":"https://www.artificialintelligence-news.com/news/neko-health-700m-ai-body-scans-us","datePublished":"2026-07-16T09:00:00.000Z","provider":{"@type":"Organization","name":"artificialintelligence-news.com","url":"https://www.artificialintelligence-news.com/news/neko-health-700m-ai-body-scans-us"}},{"@type":"CreativeWork","name":"AIHot archive record","url":"https://aihot.virxact.com/items/cmrnakp7k00pybic6jidcx726","datePublished":"2026-07-16T09:00:00.000Z","provider":{"@type":"Organization","name":"AIHot","url":"https://aihot.virxact.com/items/cmrnakp7k00pybic6jidcx726"}}],"aggregationSource":"Artificial Intelligence News（RSS）","originalPublisher":{"name":"artificialintelligence-news.com","url":"https://www.artificialintelligence-news.com/news/neko-health-700m-ai-body-scans-us"},"article":{"id":"cmrnakp7k00pybic6jidcx726","slug":"cmrnakp7k00pybic6jidcx726","url":"https://www.aioga.com/news/cmrnakp7k00pybic6jidcx726/","title":"Neko Health 完成 7 亿美元C轮融资，将在纽约开设首家美国诊所","title_en":"Neko Health raises $700 million to expand AI body scans in the US","summary":"Neko Health 完成 7 亿美元 C 轮融资，由 Lightspeed Venture Partners 领投，计划在纽约开设首家美国诊所。其 60 分钟非侵入性健康评估结合医学影像、血液检测与自有传感器，可筛查皮肤癌、心血管疾病等迹象。公司自 2023 年推出以来已完成 10 万次扫描，在英国和瑞典运营 8 家诊所。","source":"Artificial Intelligence News（RSS）","sourceUrl":"https://www.artificialintelligence-news.com/news/neko-health-700m-ai-body-scans-us","aiHotUrl":"https://aihot.virxact.com/items/cmrnakp7k00pybic6jidcx726","publishedAt":"2026-07-16T09:00:00.000Z","category":"行业动态","score":55,"selected":false,"articleBody":["Neko Health has raised $700 million to expand its AI body scans in the United States, starting with a clinic in New York. The company’s preventive screening service combines medical imaging, blood tests, proprietary sensors, and clinician review.","The Series C round was led by Lightspeed Venture Partners and co-led by O.G. Venture Partners. Existing investors Atomico, General Catalyst, and Lakestar participated, alongside new backers including Liberty City Ventures, Positive Sum, and BDT & MSD.","David Ofer of O.G. Venture Partners will join Neko’s board, subject to regulatory approval.","The latest round brings Neko’s disclosed funding since 2023 to more than $1 billion. The company raised $65 million in a Series A round in 2023 and another $260 million in January 2025.","The round also included investments from Meta chief executive Mark Zuckerberg and Priscilla Chan, former tennis player Maria Sharapova, musician will.i.am, and former footballer Thierry Henry. Existing individual investors include Reddit co-founder Alexis Ohanian and actor Zoë Saldaña.","Neko operates clinics that combine full-body scans, blood tests, artificial intelligence, and custom-built medical equipment. The service screens customers for potential signs of conditions including skin cancer, cardiovascular disease, and diabetes.","The company describes the service as a 60-minute, non-invasive, and radiation-free health assessment. It uses proprietary sensors and blood analysis to examine skin conditions, blood abnormalities, pre-diabetes indicators, and risk factors associated with metabolic syndrome, stroke, and heart attack.","The scan also includes an electrocardiogram, arterial measurements, body-composition analysis, and more than 2,000 high-resolution images used to map a customer’s skin. Blood samples are processed at the clinic, allowing the results to be reviewed during the same visit.","Results are discussed during an in-person consultation with a medical professional.","Many of the measurements, including blood pressure, blood glucose, cholesterol, electrocardiogram data, and skin assessments, are already available through conventional healthcare services. Neko’s model combines them with proprietary imaging, automated data collection, on-site blood processing, and a clinician consultation in one appointment.","The company’s public clinical materials reviewed for this article do not include a comparative study showing whether this combined approach improves clinical outcomes or cost-effectiveness compared with established preventive-care pathways.","Neko said the funding will support the opening of clinics in New York and other US cities. It has not identified the additional locations or provided a detailed expansion schedule.","A waitlist for the New York clinic is open on the company’s website. Neko has not disclosed how much its US scans will cost.","The company currently operates eight clinics across the UK and Sweden, including two in Stockholm, one each in Manchester and Birmingham, and four in London: Marylebone, Spitalfields, Covent Garden, and Victoria.","A scan costs £299 in the UK and 2,750 Swedish kronor in Sweden, equivalent to about $400 and $285.","Neko said it has completed 100,000 scans since launching its service in 2023. More than 350,000 people have registered for a scan or joined its waitlists.","According to the company, 75% of customers book and prepay for another scan at the end of their appointment.","The repeat-booking model allows clinicians to compare measurements and skin images over time. Public information reviewed for this article does not include evidence establishing whether annual screening is the appropriate interval for every age or risk group.","Founded in 2018 by Spotify co-founder Daniel Ek and chief executive Hjalmar Nilsonne, Neko operated largely outside public view until launching its service in 2023.","Nilsonne said part of the new capital will fund further research and development into preventive screening technology.","Neko recently added body-composition measurements and clinician reviews of wearable-device data across its clinics. It has also introduced updated versions of its Derma, Echo, and Spectrum medical devices, which collect information relating to skin, heart function, and circulation.","The company said the newer equipment captures a larger volume of health data and automates more parts of the scanning process. It plans to deploy the devices across its clinics in the coming months.","The clinic-based model requires proprietary equipment, blood-processing capacity, medical personnel, and specialist review for some findings. Neko said its seven-room Covent Garden clinic was designed to support tens of thousands of scans annually, but it has not disclosed capacity or staffing figures for its planned US locations.","FDA records show that two of Neko’s internally developed devices received clearance through the agency’s 510(k) pathway in May 2026. Derma-2 was cleared as an adjunctive telethermographic system, while Spectrum-2 was cleared as a tissue-saturation oximeter used in cardiovascular measurements.","The clearances apply to the specified devices and their intended uses, rather than to the complete Neko Health Scan as a single FDA-approved screening service.","The company says specialist clinicians, including dermatologists and cardiologists, review findings that require further examination. Follow-up appointments, referral letters, and introductions to outside specialists are included when recommended by a Neko clinician.","Neko’s US clinics do not currently participate in health insurance plans, and the company says most of its services are not covered by a payer. Customers are therefore expected to pay directly for the initial assessment.","The company has not disclosed what customers would pay for diagnostic tests or treatment delivered by external healthcare providers. It has also not announced its US price or whether employers, insurers, or other organisations will subsidise access to the service.","Publicly available information reviewed for this article does not include a completed peer-reviewed study validating the full screening service. A study registered on ClinicalTrials.gov is evaluating the suitability of Neko’s multimodal skin-imaging technology for screening and diagnostic-support applications, including skin cancer and Raynaud’s phenomenon.","The trial remains an ongoing evaluation and does not establish the clinical performance of the complete Neko Health Scan.","Neko’s public materials reviewed for this article do not disclose how often its scans produce false-positive findings, how many customers undergo additional procedures, or how many flagged abnormalities are later considered clinically unimportant.","Public information does not provide a complete breakdown of which scan measurements or classifications rely on AI, conventional software, or direct clinical assessment. It also does not state that AI independently diagnoses the conditions covered by the service.","The FDA clearances for individual devices do not establish the performance of every algorithm used to combine or interpret the resulting data. Public materials reviewed for this article do not include detailed real-world performance figures for each AI system used in the screening process.","Neko’s reported health-outcome data is based on 1,469 customers who completed a second scan approximately one year after their first. The company said the group recorded improvements in blood pressure, cholesterol, and blood sugar, while body weight remained broadly stable.","The scans in the analysis were conducted at Neko’s Stockholm clinics. The company divided the results into a general group, a healthy group, and groups covering customers with hypertension, pre-diabetes, or diabetes.","Neko said the analysis was not a scientific study and did not include a control group. Customers could have started treatment or changed their behaviour between appointments, so the figures do not establish that the scans caused the reported improvements.","The analysis only covered customers who returned for a second privately purchased scan. Neko did not publish demographic information showing how that group compares with its wider customer base or the general population.","The company did not disclose its valuation following the latest round. The Financial Times, citing unnamed sources, reported that Neko is now valued at about $7 billion.","(Photo by Wonderlane：https://unsplash.com/@wonderlane?utm_source=unsplash&utm_medium=referral&utm_content=creditCopyText)","See also: NHS AI blood test could reduce invasive womb cancer checks：https://www.artificialintelligence-news.com/news/nhs-ai-blood-test-womb-cancer-checks/","Want to learn more about AI and big data from industry leaders? Check out AI & Big Data Expo：https://www.ai-expo.net/?utm_source=AI-News&utm_medium=Footer-banner&utm_campaign=world-series taking place in Amsterdam, California, and London. The comprehensive event is part of TechEx：https://techexevent.com/?utm_source=AI-News&utm_medium=Footer-banner&utm_campaign=world-series and is co-located with other leading technology events, click here：https://techexevent.com/?utm_source=AI-News&utm_medium=Footer-banner&utm_campaign=world-series for more information.","AI News is powered by TechForge Media：https://techforge.pub/?utm_source=AI-News&utm_medium=Footer-banner&utm_campaign=world-series. Explore other upcoming enterprise technology events and webinars here：https://techforge.pub/events/?utm_source=AI-News&utm_medium=Footer-banner&utm_campaign=world-series.","Muhammad Zulhusni：https://www.artificialintelligence-news.com/news/author/muhammadzulhusni/","Physical AI：https://www.artificialintelligence-news.com/categories/ai-and-us/physical-ai/","AI Business Strategy：https://www.artificialintelligence-news.com/categories/inside-ai/ai-business-strategy/, Artificial Intelligence：https://www.artificialintelligence-news.com/categories/artificial-intelligence/, Features：https://www.artificialintelligence-news.com/categories/features/, Finance AI：https://www.artificialintelligence-news.com/categories/ai-in-action/finance-ai/, World of Work：https://www.artificialintelligence-news.com/categories/ai-and-us/world-of-work/","AI in Action：https://www.artificialintelligence-news.com/categories/ai-in-action/, AI Market Trends：https://www.artificialintelligence-news.com/categories/inside-ai/ai-market-trends/, Artificial Intelligence：https://www.artificialintelligence-news.com/categories/artificial-intelligence/, Human-AI Relationships：https://www.artificialintelligence-news.com/categories/ai-and-us/human-ai-relationships/, Inside AI：https://www.artificialintelligence-news.com/categories/inside-ai/, Manufacturing & Engineering AI：https://www.artificialintelligence-news.com/categories/ai-in-action/manufacturing-engineering-ai/, Physical AI：https://www.artificialintelligence-news.com/categories/ai-and-us/physical-ai/","AI in Action：https://www.artificialintelligence-news.com/categories/ai-in-action/","World of Work：https://www.artificialintelligence-news.com/categories/ai-and-us/world-of-work/","Healthcare & Wellness AI：https://www.artificialintelligence-news.com/categories/ai-in-action/healthcare-wellness-ai/","All our premium content and latest tech news delivered straight to your inbox","AI News is part of TechForge：https://techforge.pub/"],"articleImages":[{"sourceUrl":"https://www.artificialintelligence-news.com/wp-content/uploads/2026/06/image-300x37.png","alt":"Banner for AI & Big Data Expo by TechEx events.","afterParagraph":39,"url":"/media/articles/cmrnakp7k00pybic6jidcx726/1a537e7502a00912.png"},{"sourceUrl":"https://www.artificialintelligence-news.com/wp-content/uploads/2024/05/muhammadprof.jpeg","alt":"","afterParagraph":41,"url":"/media/articles/cmrnakp7k00pybic6jidcx726/244ae24f1a11ac92.jpg"},{"sourceUrl":"https://www.artificialintelligence-news.com/wp-content/uploads/2026/06/Airia-webinar.png","alt":"","afterParagraph":45,"url":"/media/articles/cmrnakp7k00pybic6jidcx726/09f94645ae1f29f3.png"},{"sourceUrl":"https://www.artificialintelligence-news.com/wp-content/uploads/2025/01/300x600-150x300.png","alt":"","afterParagraph":45,"url":"/media/articles/cmrnakp7k00pybic6jidcx726/84efdfaa93523a46.png"},{"sourceUrl":"https://www.artificialintelligence-news.com/wp-content/uploads/2026/07/kate-sade-2zZp12ChxhU-unsplash-2048x1360.jpg","alt":"","afterParagraph":46,"url":"/media/articles/cmrnakp7k00pybic6jidcx726/a9bee7c3309eeae6.jpg"},{"sourceUrl":"https://www.artificialintelligence-news.com/wp-content/uploads/2026/07/aws-graphrag-deployment-drug-research-report-amazon-web-services-enterprise-ai-healthcare-2048x1536.jpg","alt":"","afterParagraph":47,"url":"/media/articles/cmrnakp7k00pybic6jidcx726/2e0663598d1dc0b9.jpg"}],"mediaStatus":"ok","articleBodyZh":["Neko Health 已筹集 7 亿美元用于在美国扩展其人工智能全身扫描服务，首站将在纽约开设诊所。该公司的预防性筛查服务结合了医学影像、血液检测、专有传感器和临床医生评估。","C 轮融资由 Lightspeed 风险投资公司领投，O.G. Venture Partners 共同领投。现有投资者 Atomico、General Catalyst 和 Lakestar 参与了本轮融资，同时新投资者包括 Liberty City Ventures、Positive Sum 和 BDT & MSD。","O.G. Venture Partners 的 David Ofer 将加入 Neko 的董事会，需符合监管审批。","此次融资使 Neko 自 2023 年以来的披露融资总额超过 10 亿美元。该公司在 2023 年完成了 6,500 万美元的 A 轮融资，并在 2025 年 1 月增加了 2.6 亿美元的融资。","本轮还包括来自 Meta 首席执行官马克·扎克伯格和 Priscilla Chan、前网球运动员玛丽亚·莎拉波娃、音乐人 will.i.am 以及前足球运动员蒂埃里·亨利的投资。现有个人投资者包括 Reddit 联合创始人 Alexis Ohanian 和演员 Zoë Saldaña。","Neko 运营结合全身扫描、血液检测、人工智能及定制医疗设备的诊所。该服务为客户筛查包括皮肤癌、心血管疾病和糖尿病在内的潜在健康状况的早期迹象。","公司将该服务描述为 60 分钟、非侵入性且无辐射的健康评估。它利用专有传感器和血液分析检查皮肤状况、血液异常、前期糖尿病指标，以及与代谢综合征、中风和心脏病相关的风险因素。","扫描还包括心电图、动脉测量、身体成分分析，以及用于绘制客户皮肤的 2,000 多张高分辨率图像。血液样本在诊所处理，使结果可在同一次就诊期间进行评估。","结果将在与医疗专业人士的面对面咨询过程中讨论。","许多测量，包括血压、血糖、胆固醇、心电图数据以及皮肤评估，已经可以通过传统医疗服务获得。Neko 的模式将这些与专有成像技术、自动化数据收集、现场血液处理以及一次性临床咨询结合在一次预约中。","本文审阅的公司公开临床资料中不包括比较研究，无法显示这种综合方法是否比既有的预防护理路径在临床结果或成本效益方面有所改善。","Neko 表示，这笔资金将支持在纽约及美国其他城市开设诊所。公司尚未确定更多具体地点，也没有提供详细的扩展时间表。","纽约诊所的候诊名单已在公司网站上开放。Neko 尚未公开其在美国的扫描费用。","公司目前在英国和瑞典运营八家诊所，包括斯德哥尔摩两家、曼彻斯特和伯明翰各一，以及伦敦四家：玛丽勒本、斯皮塔菲尔德、科文特花园和维多利亚。","在英国一次扫描费用为 299 英镑，在瑞典为 2,750 瑞典克朗，约合 400 美元和 285 美元。","Neko 表示，自 2023 年推出服务以来，已完成 100,000 次扫描。已有超过 350,000 人注册扫描或加入候诊名单。","根据公司表示，75% 的客户在预约结束时会预订并预付另一次扫描。","重复预订模式使临床医生能够随时间比较测量结果和皮肤图像。本文审阅的公开信息中，不包括证据证明年检筛查对每个年龄或风险组都是适当间隔。","Neko 由 Spotify 联合创始人 Daniel Ek 和首席执行官 Hjalmar Nilsonne 于 2018 年创立，在 2023 年推出服务前大部分时间公司运营较为低调。","Nilsonne 表示，新资金的一部分将用于进一步研发预防筛查技术。","Neko 最近在其诊所中增加了体成分测量和临床医生对可穿戴设备数据的评估。它还推出了更新版本的 Derma、Echo 和 Spectrum 医疗设备，这些设备收集与皮肤、心脏功能和血液循环相关的信息。","公司表示，新设备能够捕获更多的健康数据，并自动化扫描过程中的更多环节。计划在未来几个月内在其诊所部署这些设备。","基于诊所的模式需要专有设备、血液处理能力、医疗人员以及某些发现的专家审核。Neko 表示，其位于考文特花园的七间房间诊所设计可支持每年数万次扫描，但尚未披露其计划在美国设立的地点的容量或人员配置数据。","FDA 记录显示，Neko 自主开发的两款设备在 2026 年 5 月通过该机构的 510(k) 路径获得批准。Derma-2 被批准作为辅助远程热成像系统，而 Spectrum-2 被批准作为用于心血管测量的组织饱和度血氧仪。","这些批准适用于指定的设备及其预期用途，而不是作为单一 FDA 批准的筛查服务的完整 Neko 健康扫描。","公司表示，需进一步检查的发现会由包括皮肤科医生和心脏科医生在内的专家临床医生进行审核。在 Neko 临床医生的建议下，还会包括随访预约、转诊信以及引介到外部专家的服务。","Neko 的美国诊所目前不参与健康保险计划，公司表示其大部分服务不由支付方覆盖。因此，客户需直接支付初步评估费用。","公司尚未披露客户需支付的外部医疗服务提供者的诊断测试或治疗费用，也未公布美国的定价，或是否由雇主、保险公司或其他机构补贴服务访问费用。","本文审查的公开信息中不包括验证完整筛查服务的已完成同行评审研究。一项在ClinicalTrials.gov注册的研究正在评估Neko多模态皮肤成像技术用于筛查和诊断支持应用的适用性，包括皮肤癌和雷诺现象。","该试验仍在进行中评估，并未确定完整Neko健康扫描的临床表现。","本文审查的Neko公开资料未披露其扫描产生假阳性结果的频率、有多少客户接受了额外程序，或多少被标记的异常后来被认为在临床上不重要。","公开信息未提供哪些扫描测量或分类依赖于人工智能、传统软件或直接临床评估的完整细分。信息中也未说明人工智能独立诊断服务覆盖的病症。","各个设备的FDA认证并不能确定用于组合或解释所得到数据的每一个算法的表现。本文审查的公开资料中未包含用于筛查过程的每个AI系统的详细实际性能数据。","Neko报告的健康结局数据基于1,469名客户在首次扫描约一年后完成的第二次扫描。公司表示，该组客户记录了血压、胆固醇和血糖的改善，而体重大体上保持稳定。","分析中的扫描是在Neko斯德哥尔摩诊所进行的。公司将结果分为一般组、健康组，以及包括高血压、糖尿病前期或糖尿病客户的分组。","Neko表示，该分析并非科学研究，也未包含对照组。客户在两次预约之间可能已开始治疗或改变行为，因此这些数据并不能确认扫描导致了报告的改善。","分析仅涵盖返回接受第二次私人购买扫描的客户。Neko未发布体现该群体与其更广泛客户群或普通人群比较的人口统计信息。","公司在最新一轮融资后未披露其估值。《金融时报》援引未具名的消息来源报道，Neko 目前的估值约为 70 亿美元。","（照片来源 Wonderlane：https://unsplash.com/@wonderlane?utm_source=unsplash&utm_medium=referral&utm_content=creditCopyText）","另请参见：NHS 人工智能血液检测可减少侵入性子宫癌检查：https://www.artificialintelligence-news.com/news/nhs-ai-blood-test-womb-cancer-checks/","想了解行业领导者关于人工智能和大数据的更多信息吗？请查看 AI & 大数据博览会：https://www.ai-expo.net/?utm_source=AI-News&utm_medium=Footer-banner&utm_campaign=world-series，该活动将在阿姆斯特丹、加利福尼亚和伦敦举行。该综合性活动是 TechEx 的一部分：https://techexevent.com/?utm_source=AI-News&utm_medium=Footer-banner&utm_campaign=world-series，并与其他领先科技活动共同举办，点击这里：https://techexevent.com/?utm_source=AI-News&utm_medium=Footer-banner&utm_campaign=world-series 获取更多信息。","AI 新闻由 TechForge Media 提供技术支持：https://techforge.pub/?utm_source=AI-News&utm_medium=Footer-banner&utm_campaign=world-series。在此探索其他即将举行的企业科技活动和网络研讨会：https://techforge.pub/events/?utm_source=AI-News&utm_medium=Footer-banner&utm_campaign=world-series。","Muhammad Zulhusni：https://www.artificialintelligence-news.com/news/author/muhammadzulhusni/","物理人工智能：https://www.artificialintelligence-news.com/categories/ai-and-us/physical-ai/","人工智能商业策略：https://www.artificialintelligence-news.com/categories/inside-ai/ai-business-strategy/、人工智能：https://www.artificialintelligence-news.com/categories/artificial-intelligence/、专题报道：https://www.artificialintelligence-news.com/categories/features/、金融人工智能：https://www.artificialintelligence-news.com/categories/ai-in-action/finance-ai/、工作世界：https://www.artificialintelligence-news.com/categories/ai-and-us/world-of-work/","行动中的人工智能：https://www.artificialintelligence-news.com/categories/ai-in-action/，人工智能市场趋势：https://www.artificialintelligence-news.com/categories/inside-ai/ai-market-trends/，人工智能：https://www.artificialintelligence-news.com/categories/artificial-intelligence/，人机关系：https://www.artificialintelligence-news.com/categories/ai-and-us/human-ai-relationships/，AI内部资讯：https://www.artificialintelligence-news.com/categories/inside-ai/，制造与工程AI：https://www.artificialintelligence-news.com/categories/ai-in-action/manufacturing-engineering-ai/，物理AI：https://www.artificialintelligence-news.com/categories/ai-and-us/physical-ai/","行动中的人工智能：https://www.artificialintelligence-news.com/categories/ai-in-action/","职场世界：https://www.artificialintelligence-news.com/categories/ai-and-us/world-of-work/","医疗保健与健康AI：https://www.artificialintelligence-news.com/categories/ai-in-action/healthcare-wellness-ai/","我们所有的优质内容和最新科技新闻直接发送到您的邮箱","AI新闻是TechForge的一部分：https://techforge.pub/"],"translationStatus":"translated","bodyOrigin":"source-page","editorial":{"summary":"Aioga 编辑摘要：Neko Health 完成 7 亿美元 C 轮融资，由 Lightspeed Venture Partners 领投，计划在纽约开设首家美国诊所。 Aioga 将其归入「行业动态」方向，重点关注它对真实使用和行业竞争的影响。","background":"背景分析：公司与行业类动态需要放在竞争格局、商业化路径、资本信号和监管环境中观察，单条公告不能代表最终结果。","viewpoint":"Aioga 判断：这条动态更适合作为行业观察信号，当前信息足以建立线索，但不足以推导长期结论。","implications":"影响分析：对相关团队而言，短期应先核对来源、可用范围和实际成本，再判断是否值得接入或跟进。","nextStep":"后续观察：继续观察官方文件、合作落地、收入或用户信号、竞品动作和监管后续。","evidenceRefs":["title","summary","articleBody"],"confidence":"medium","status":"published","aiGenerated":false,"autoApproved":true,"generatedBy":"rule-safe-fallback","generatedAt":"2026-07-23T06:49:19.217Z","sourceHash":"b4a4a5493fef3864","validation":{"passed":true,"mode":"rule-safe-fallback","checks":["schema","length","source-attribution","no-html"]}},"tags":["行业动态","Artificial Intelligence News（RSS）"],"translations":{"zh-CN":{"title":"Neko Health 完成 7 亿美元C轮融资，将在纽约开设首家美国诊所","summary":"Neko Health 完成 7 亿美元 C 轮融资，由 Lightspeed Venture Partners 领投，计划在纽约开设首家美国诊所。其 60 分钟非侵入性健康评估结合医学影像、血液检测与自有传感器，可筛查皮肤癌、心血管疾病等迹象。公司自 2023 年推出以来已完成 10 万次扫描，在英国和瑞典运营 8 家诊所。","category":"行业动态","source":"Artificial Intelligence News（RSS）","aggregationSource":"Artificial Intelligence News（RSS）","pageTitle":"Neko Health 完成 7 亿美元C轮融资，将在纽约开设首家美国诊所 - Aioga AI资讯","description":"Neko Health 完成 7 亿美元 C 轮融资，由 Lightspeed Venture Partners 领投，计划在纽约开设首家美国诊所。其 60 分钟非侵入性健康评估结合医学影像、血液检测与自有传感器，可筛查皮肤癌、心血管疾病等迹象。公司自 2023 年推出以来已完成 10 万次扫描，在英国和瑞典运营 8 家诊所。","url":"https://www.aioga.com/news/cmrnakp7k00pybic6jidcx726/"},"en":{"title":"Neko Health raises $700 million to expand AI body scans in the US","summary":"Aioga tracks this update from Artificial Intelligence News（RSS） under Industry. Neko Health 完成 7 亿美元 C 轮融资，由 Lightspeed Venture Partners 领投，计划在纽约开设首家美国诊所。其 60 分钟非侵入性健康评估结合医学影像、血液检测与自有传感器，可筛查皮肤癌、心血管疾病等迹象。公司自 2023 年推出以来已完成 10 万次扫描，在英国和瑞典运营 8 家诊所。","category":"Industry","source":"Artificial Intelligence News（RSS）","aggregationSource":"Artificial Intelligence News（RSS）","pageTitle":"Neko Health raises $700 million to expand AI body scans in the US - Aioga AI News","description":"Aioga tracks this update from Artificial Intelligence News（RSS） under Industry. Neko Health 完成 7 亿美元 C 轮融资，由 Lightspeed Venture Partners 领投，计划在纽约开设首家美国诊所。其 60 分钟非侵入性健康评估结合医学影像、血液检测","url":"https://www.aioga.com/en/news/cmrnakp7k00pybic6jidcx726/"},"ja":{"title":"Neko Health 完成 7 亿美元C轮融资，将在纽约开设首家美国诊所","summary":"Aiogaは「業界動向」の動きとして、Artificial Intelligence News（RSS） からの更新を追跡しています。Neko Health 完成 7 亿美元 C 轮融资，由 Lightspeed Venture Partners 领投，计划在纽约开设首家美国诊所。其 60 分钟非侵入性健康评估结合医学影像、血液检测与自有传感器，可筛查皮肤癌、心血管疾病等迹象。公司自 2023 年推出以来已完成 10 万次扫描，在英国和瑞典运营 8 家诊所。","category":"業界動向","source":"Artificial Intelligence News（RSS）","aggregationSource":"Artificial Intelligence News（RSS）","pageTitle":"Neko Health 完成 7 亿美元C轮融资，将在纽约开设首家美国诊所 - Aioga AIニュース","description":"Aiogaは「業界動向」の動きとして、Artificial Intelligence News（RSS） からの更新を追跡しています。Neko Health 完成 7 亿美元 C 轮融资，由 Lightspeed Venture Partners 领投，计划在纽约开设首家美国诊所。其 60 分钟非侵入性健康评估结合医学影像、血液检测与自有传感器，可筛查皮肤癌","url":"https://www.aioga.com/ja/news/cmrnakp7k00pybic6jidcx726/"},"ko":{"title":"Neko Health 完成 7 亿美元C轮融资，将在纽约开设首家美国诊所","summary":"Aioga는 Artificial Intelligence News（RSS）의 업데이트를 업계 동향 흐름으로 추적합니다. Neko Health 完成 7 亿美元 C 轮融资，由 Lightspeed Venture Partners 领投，计划在纽约开设首家美国诊所。其 60 分钟非侵入性健康评估结合医学影像、血液检测与自有传感器，可筛查皮肤癌、心血管疾病等迹象。公司自 2023 年推出以来已完成 10 万次扫描，在英国和瑞典运营 8 家诊所。","category":"업계 동향","source":"Artificial Intelligence News（RSS）","aggregationSource":"Artificial Intelligence News（RSS）","pageTitle":"Neko Health 完成 7 亿美元C轮融资，将在纽约开设首家美国诊所 - Aioga AI 뉴스","description":"Aioga는 Artificial Intelligence News（RSS）의 업데이트를 업계 동향 흐름으로 추적합니다. Neko Health 完成 7 亿美元 C 轮融资，由 Lightspeed Venture Partners 领投，计划在纽约开设首家美国诊所。其 60 分钟非侵入性健康评估结合医学影像、血液检测与自有传感器，可筛查皮肤癌、","url":"https://www.aioga.com/ko/news/cmrnakp7k00pybic6jidcx726/"},"es":{"title":"Neko Health 完成 7 亿美元C轮融资，将在纽约开设首家美国诊所","summary":"Aioga sigue esta actualización de Artificial Intelligence News（RSS） dentro de Industria. Neko Health 完成 7 亿美元 C 轮融资，由 Lightspeed Venture Partners 领投，计划在纽约开设首家美国诊所。其 60 分钟非侵入性健康评估结合医学影像、血液检测与自有传感器，可筛查皮肤癌、心血管疾病等迹象。公司自 2023 年推出以来已完成 10 万次扫描，在英国和瑞典运营 8 家诊所。","category":"Industria","source":"Artificial Intelligence News（RSS）","aggregationSource":"Artificial Intelligence News（RSS）","pageTitle":"Neko Health 完成 7 亿美元C轮融资，将在纽约开设首家美国诊所 - Aioga Noticias de IA","description":"Aioga sigue esta actualización de Artificial Intelligence News（RSS） dentro de Industria. Neko Health 完成 7 亿美元 C 轮融资，由 Lightspeed Venture Partners 领投，计划在纽约开设首家美国诊所。其 60 分钟非侵入性健康评估结合","url":"https://www.aioga.com/es/news/cmrnakp7k00pybic6jidcx726/"},"fr":{"title":"Neko Health 完成 7 亿美元C轮融资，将在纽约开设首家美国诊所","summary":"Aioga suit cette mise à jour de Artificial Intelligence News（RSS） dans la catégorie Industrie. Neko Health 完成 7 亿美元 C 轮融资，由 Lightspeed Venture Partners 领投，计划在纽约开设首家美国诊所。其 60 分钟非侵入性健康评估结合医学影像、血液检测与自有传感器，可筛查皮肤癌、心血管疾病等迹象。公司自 2023 年推出以来已完成 10 万次扫描，在英国和瑞典运营 8 家诊所。","category":"Industrie","source":"Artificial Intelligence News（RSS）","aggregationSource":"Artificial Intelligence News（RSS）","pageTitle":"Neko Health 完成 7 亿美元C轮融资，将在纽约开设首家美国诊所 - Aioga Actualités IA","description":"Aioga suit cette mise à jour de Artificial Intelligence News（RSS） dans la catégorie Industrie. Neko Health 完成 7 亿美元 C 轮融资，由 Lightspeed Venture Partners 领投，计划在纽约开设首家美国诊所。其 60 分钟非侵入性","url":"https://www.aioga.com/fr/news/cmrnakp7k00pybic6jidcx726/"},"de":{"title":"Neko Health 完成 7 亿美元C轮融资，将在纽约开设首家美国诊所","summary":"Aioga tracks this update from Artificial Intelligence News（RSS） under 行业动态. Neko Health 完成 7 亿美元 C 轮融资，由 Lightspeed Venture Partners 领投，计划在纽约开设首家美国诊所。其 60 分钟非侵入性健康评估结合医学影像、血液检测与自有传感器，可筛查皮肤癌、心血管疾病等迹象。公司自 2023 年推出以来已完成 10 万次扫描，在英国和瑞典运营 8 家诊所。","category":"行业动态","source":"Artificial Intelligence News（RSS）","aggregationSource":"Artificial Intelligence News（RSS）","pageTitle":"Neko Health 完成 7 亿美元C轮融资，将在纽约开设首家美国诊所 - Aioga KI-News","description":"Aioga tracks this update from Artificial Intelligence News（RSS） under 行业动态. Neko Health 完成 7 亿美元 C 轮融资，由 Lightspeed Venture Partners 领投，计划在纽约开设首家美国诊所。其 60 分钟非侵入性健康评估结合医学影像、血液检测与自有传","url":"https://www.aioga.com/de/news/cmrnakp7k00pybic6jidcx726/"},"pt-BR":{"title":"Neko Health 完成 7 亿美元C轮融资，将在纽约开设首家美国诊所","summary":"Aioga tracks this update from Artificial Intelligence News（RSS） under 行业动态. Neko Health 完成 7 亿美元 C 轮融资，由 Lightspeed Venture Partners 领投，计划在纽约开设首家美国诊所。其 60 分钟非侵入性健康评估结合医学影像、血液检测与自有传感器，可筛查皮肤癌、心血管疾病等迹象。公司自 2023 年推出以来已完成 10 万次扫描，在英国和瑞典运营 8 家诊所。","category":"行业动态","source":"Artificial Intelligence News（RSS）","aggregationSource":"Artificial Intelligence News（RSS）","pageTitle":"Neko Health 完成 7 亿美元C轮融资，将在纽约开设首家美国诊所 - Aioga Notícias de IA","description":"Aioga tracks this update from Artificial Intelligence News（RSS） under 行业动态. Neko Health 完成 7 亿美元 C 轮融资，由 Lightspeed Venture Partners 领投，计划在纽约开设首家美国诊所。其 60 分钟非侵入性健康评估结合医学影像、血液检测与自有传","url":"https://www.aioga.com/pt-BR/news/cmrnakp7k00pybic6jidcx726/"},"ru":{"title":"Neko Health 完成 7 亿美元C轮融资，将在纽约开设首家美国诊所","summary":"Aioga tracks this update from Artificial Intelligence News（RSS） under 行业动态. Neko Health 完成 7 亿美元 C 轮融资，由 Lightspeed Venture Partners 领投，计划在纽约开设首家美国诊所。其 60 分钟非侵入性健康评估结合医学影像、血液检测与自有传感器，可筛查皮肤癌、心血管疾病等迹象。公司自 2023 年推出以来已完成 10 万次扫描，在英国和瑞典运营 8 家诊所。","category":"行业动态","source":"Artificial Intelligence News（RSS）","aggregationSource":"Artificial Intelligence News（RSS）","pageTitle":"Neko Health 完成 7 亿美元C轮融资，将在纽约开设首家美国诊所 - Aioga Новости ИИ","description":"Aioga tracks this update from Artificial Intelligence News（RSS） under 行业动态. Neko Health 完成 7 亿美元 C 轮融资，由 Lightspeed Venture Partners 领投，计划在纽约开设首家美国诊所。其 60 分钟非侵入性健康评估结合医学影像、血液检测与自有传","url":"https://www.aioga.com/ru/news/cmrnakp7k00pybic6jidcx726/"},"ar":{"title":"Neko Health 完成 7 亿美元C轮融资，将在纽约开设首家美国诊所","summary":"Aioga tracks this update from Artificial Intelligence News（RSS） under 行业动态. Neko Health 完成 7 亿美元 C 轮融资，由 Lightspeed Venture Partners 领投，计划在纽约开设首家美国诊所。其 60 分钟非侵入性健康评估结合医学影像、血液检测与自有传感器，可筛查皮肤癌、心血管疾病等迹象。公司自 2023 年推出以来已完成 10 万次扫描，在英国和瑞典运营 8 家诊所。","category":"行业动态","source":"Artificial Intelligence News（RSS）","aggregationSource":"Artificial Intelligence News（RSS）","pageTitle":"Neko Health 完成 7 亿美元C轮融资，将在纽约开设首家美国诊所 - Aioga أخبار الذكاء الاصطناعي","description":"Aioga tracks this update from Artificial Intelligence News（RSS） under 行业动态. Neko Health 完成 7 亿美元 C 轮融资，由 Lightspeed Venture Partners 领投，计划在纽约开设首家美国诊所。其 60 分钟非侵入性健康评估结合医学影像、血液检测与自有传","url":"https://www.aioga.com/ar/news/cmrnakp7k00pybic6jidcx726/"},"hi":{"title":"Neko Health 完成 7 亿美元C轮融资，将在纽约开设首家美国诊所","summary":"Aioga tracks this update from Artificial Intelligence News（RSS） under 行业动态. Neko Health 完成 7 亿美元 C 轮融资，由 Lightspeed Venture Partners 领投，计划在纽约开设首家美国诊所。其 60 分钟非侵入性健康评估结合医学影像、血液检测与自有传感器，可筛查皮肤癌、心血管疾病等迹象。公司自 2023 年推出以来已完成 10 万次扫描，在英国和瑞典运营 8 家诊所。","category":"行业动态","source":"Artificial Intelligence News（RSS）","aggregationSource":"Artificial Intelligence News（RSS）","pageTitle":"Neko Health 完成 7 亿美元C轮融资，将在纽约开设首家美国诊所 - Aioga AI समाचार","description":"Aioga tracks this update from Artificial Intelligence News（RSS） under 行业动态. Neko Health 完成 7 亿美元 C 轮融资，由 Lightspeed Venture Partners 领投，计划在纽约开设首家美国诊所。其 60 分钟非侵入性健康评估结合医学影像、血液检测与自有传","url":"https://www.aioga.com/hi/news/cmrnakp7k00pybic6jidcx726/"},"it":{"title":"Neko Health 完成 7 亿美元C轮融资，将在纽约开设首家美国诊所","summary":"Aioga tracks this update from Artificial Intelligence News（RSS） under 行业动态. Neko Health 完成 7 亿美元 C 轮融资，由 Lightspeed Venture Partners 领投，计划在纽约开设首家美国诊所。其 60 分钟非侵入性健康评估结合医学影像、血液检测与自有传感器，可筛查皮肤癌、心血管疾病等迹象。公司自 2023 年推出以来已完成 10 万次扫描，在英国和瑞典运营 8 家诊所。","category":"行业动态","source":"Artificial Intelligence News（RSS）","aggregationSource":"Artificial Intelligence News（RSS）","pageTitle":"Neko Health 完成 7 亿美元C轮融资，将在纽约开设首家美国诊所 - Aioga Notizie IA","description":"Aioga tracks this update from Artificial Intelligence News（RSS） under 行业动态. Neko Health 完成 7 亿美元 C 轮融资，由 Lightspeed Venture Partners 领投，计划在纽约开设首家美国诊所。其 60 分钟非侵入性健康评估结合医学影像、血液检测与自有传","url":"https://www.aioga.com/it/news/cmrnakp7k00pybic6jidcx726/"},"nl":{"title":"Neko Health 完成 7 亿美元C轮融资，将在纽约开设首家美国诊所","summary":"Aioga tracks this update from Artificial Intelligence News（RSS） under 行业动态. Neko Health 完成 7 亿美元 C 轮融资，由 Lightspeed Venture Partners 领投，计划在纽约开设首家美国诊所。其 60 分钟非侵入性健康评估结合医学影像、血液检测与自有传感器，可筛查皮肤癌、心血管疾病等迹象。公司自 2023 年推出以来已完成 10 万次扫描，在英国和瑞典运营 8 家诊所。","category":"行业动态","source":"Artificial Intelligence News（RSS）","aggregationSource":"Artificial Intelligence News（RSS）","pageTitle":"Neko Health 完成 7 亿美元C轮融资，将在纽约开设首家美国诊所 - Aioga AI-nieuws","description":"Aioga tracks this update from Artificial Intelligence News（RSS） under 行业动态. Neko Health 完成 7 亿美元 C 轮融资，由 Lightspeed Venture Partners 领投，计划在纽约开设首家美国诊所。其 60 分钟非侵入性健康评估结合医学影像、血液检测与自有传","url":"https://www.aioga.com/nl/news/cmrnakp7k00pybic6jidcx726/"},"tr":{"title":"Neko Health 完成 7 亿美元C轮融资，将在纽约开设首家美国诊所","summary":"Aioga tracks this update from Artificial Intelligence News（RSS） under 行业动态. Neko Health 完成 7 亿美元 C 轮融资，由 Lightspeed Venture Partners 领投，计划在纽约开设首家美国诊所。其 60 分钟非侵入性健康评估结合医学影像、血液检测与自有传感器，可筛查皮肤癌、心血管疾病等迹象。公司自 2023 年推出以来已完成 10 万次扫描，在英国和瑞典运营 8 家诊所。","category":"行业动态","source":"Artificial Intelligence News（RSS）","aggregationSource":"Artificial Intelligence News（RSS）","pageTitle":"Neko Health 完成 7 亿美元C轮融资，将在纽约开设首家美国诊所 - Aioga AI Haberleri","description":"Aioga tracks this update from Artificial Intelligence News（RSS） under 行业动态. Neko Health 完成 7 亿美元 C 轮融资，由 Lightspeed Venture Partners 领投，计划在纽约开设首家美国诊所。其 60 分钟非侵入性健康评估结合医学影像、血液检测与自有传","url":"https://www.aioga.com/tr/news/cmrnakp7k00pybic6jidcx726/"},"vi":{"title":"Neko Health 完成 7 亿美元C轮融资，将在纽约开设首家美国诊所","summary":"Aioga tracks this update from Artificial Intelligence News（RSS） under 行业动态. Neko Health 完成 7 亿美元 C 轮融资，由 Lightspeed Venture Partners 领投，计划在纽约开设首家美国诊所。其 60 分钟非侵入性健康评估结合医学影像、血液检测与自有传感器，可筛查皮肤癌、心血管疾病等迹象。公司自 2023 年推出以来已完成 10 万次扫描，在英国和瑞典运营 8 家诊所。","category":"行业动态","source":"Artificial Intelligence News（RSS）","aggregationSource":"Artificial Intelligence News（RSS）","pageTitle":"Neko Health 完成 7 亿美元C轮融资，将在纽约开设首家美国诊所 - Tin tức AI Aioga","description":"Aioga tracks this update from Artificial Intelligence News（RSS） under 行业动态. Neko Health 完成 7 亿美元 C 轮融资，由 Lightspeed Venture Partners 领投，计划在纽约开设首家美国诊所。其 60 分钟非侵入性健康评估结合医学影像、血液检测与自有传","url":"https://www.aioga.com/vi/news/cmrnakp7k00pybic6jidcx726/"},"id":{"title":"Neko Health 完成 7 亿美元C轮融资，将在纽约开设首家美国诊所","summary":"Aioga tracks this update from Artificial Intelligence News（RSS） under 行业动态. Neko Health 完成 7 亿美元 C 轮融资，由 Lightspeed Venture Partners 领投，计划在纽约开设首家美国诊所。其 60 分钟非侵入性健康评估结合医学影像、血液检测与自有传感器，可筛查皮肤癌、心血管疾病等迹象。公司自 2023 年推出以来已完成 10 万次扫描，在英国和瑞典运营 8 家诊所。","category":"行业动态","source":"Artificial Intelligence News（RSS）","aggregationSource":"Artificial Intelligence News（RSS）","pageTitle":"Neko Health 完成 7 亿美元C轮融资，将在纽约开设首家美国诊所 - Berita AI Aioga","description":"Aioga tracks this update from Artificial Intelligence News（RSS） under 行业动态. Neko Health 完成 7 亿美元 C 轮融资，由 Lightspeed Venture Partners 领投，计划在纽约开设首家美国诊所。其 60 分钟非侵入性健康评估结合医学影像、血液检测与自有传","url":"https://www.aioga.com/id/news/cmrnakp7k00pybic6jidcx726/"},"th":{"title":"Neko Health 完成 7 亿美元C轮融资，将在纽约开设首家美国诊所","summary":"Aioga tracks this update from Artificial Intelligence News（RSS） under 行业动态. Neko Health 完成 7 亿美元 C 轮融资，由 Lightspeed Venture Partners 领投，计划在纽约开设首家美国诊所。其 60 分钟非侵入性健康评估结合医学影像、血液检测与自有传感器，可筛查皮肤癌、心血管疾病等迹象。公司自 2023 年推出以来已完成 10 万次扫描，在英国和瑞典运营 8 家诊所。","category":"行业动态","source":"Artificial Intelligence News（RSS）","aggregationSource":"Artificial Intelligence News（RSS）","pageTitle":"Neko Health 完成 7 亿美元C轮融资，将在纽约开设首家美国诊所 - ข่าว AI Aioga","description":"Aioga tracks this update from Artificial Intelligence News（RSS） under 行业动态. Neko Health 完成 7 亿美元 C 轮融资，由 Lightspeed Venture Partners 领投，计划在纽约开设首家美国诊所。其 60 分钟非侵入性健康评估结合医学影像、血液检测与自有传","url":"https://www.aioga.com/th/news/cmrnakp7k00pybic6jidcx726/"},"pl":{"title":"Neko Health 完成 7 亿美元C轮融资，将在纽约开设首家美国诊所","summary":"Aioga tracks this update from Artificial Intelligence News（RSS） under 行业动态. Neko Health 完成 7 亿美元 C 轮融资，由 Lightspeed Venture Partners 领投，计划在纽约开设首家美国诊所。其 60 分钟非侵入性健康评估结合医学影像、血液检测与自有传感器，可筛查皮肤癌、心血管疾病等迹象。公司自 2023 年推出以来已完成 10 万次扫描，在英国和瑞典运营 8 家诊所。","category":"行业动态","source":"Artificial Intelligence News（RSS）","aggregationSource":"Artificial Intelligence News（RSS）","pageTitle":"Neko Health 完成 7 亿美元C轮融资，将在纽约开设首家美国诊所 - Aioga Wiadomości AI","description":"Aioga tracks this update from Artificial Intelligence News（RSS） under 行业动态. Neko Health 完成 7 亿美元 C 轮融资，由 Lightspeed Venture Partners 领投，计划在纽约开设首家美国诊所。其 60 分钟非侵入性健康评估结合医学影像、血液检测与自有传","url":"https://www.aioga.com/pl/news/cmrnakp7k00pybic6jidcx726/"}}}}